Retatrutide 40 mg

Retatrutide 40 mg | Hudson Biotech | Investigational Peptide Supply

Secure Retatrutide 40 mg for your obesity and metabolic research today. Hudson Biotech manufactures this triple agonist (LY3437943) for sponsors, CROs, and research teams that need scalable supply and full documentation.

Specifically, NCT07467447 describes a Phase 2 trial evaluating once-weekly Retatrutide with lifestyle intervention. Therefore, we supply the same 40 mg presentation for protocols demanding batch consistency and regulatory-ready docs.

Moreover, we deliver high-purity peptide with HPLC/LC-MS verification on every lot. As a result, you get CoA, batch traceability, stability data, and controlled cold-chain logistics — no catalog compromises.

Finally, order Retatrutide 40 mg now. We allocate stock for qualified research programs and confirm lead times at quote.

However, Retatrutide remains investigational and is not FDA-approved. Thus, this product is not for personal or consumer use. For research only.